SCHEMBL4472196

SCHEMBL4472196

Nc1ccccc1C(=O)NS(=O)(=O)c1ccc(F)cc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.47
KDM4E B2RXH2 1/20 0.44
FADS1 O60427 2/20 0.44
POLB P06746 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA9 Q16790 1/20 0.43
KAT6A Q92794 3/20 0.42
HDAC1 Q13547 1/20 0.42
FLT1 P17948 2/20 0.40
FLT4 P35916 2/20 0.40
KDR P35968 2/20 0.40
P2RX1 P51575 1/20 0.40
AVPR2 P30518 1/20 0.40
GPR27 Q9NS67 1/20 0.40
EGFR P00533 1/20 0.40
KEAP1 Q14145 1/20 0.40
CCR2 P41597 1/20 0.39
KCNH2 Q12809 1/20 0.39
PIK3CB P42338 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4457676 0.80 EGFR (0.59) HPGDKDM4EPOLBCA1CA2
SCHEMBL23918989 0.79 CA9 (0.47) HPGDKDM4EFADS1CA1CA2
SCHEMBL4476657 0.77 HPGD (0.55) HPGDKDM4EFADS1POLBCA1
SCHEMBL26111565 0.75 KCNH2 (0.47) POLBKAT6ACCR2KCNH2PIK3CB
SCHEMBL4196246 0.74 CA1 (0.61) HPGDKDM4EPOLBCA1CA2
SCHEMBL22097594 0.74 KAT6A (0.39) HPGDKDM4EPOLBKAT6AFLT1
SCHEMBL4196234 0.73 KDM4E (0.68) HPGDKDM4EPOLBCA1CA2
SCHEMBL8482825 0.73 POLB (0.50) POLBCA1CA2CA9KAT6A
SCHEMBL4472201 0.72 RAB9A (0.58) POLBCA1CA2CA9AVPR2
SCHEMBL3160005 0.72 GAA (0.72) HPGDKDM4EFADS1POLBHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009067607-A2 COMBINATIONS OF PDE4 INHIBITORS AND ANTIPSYCHOTICS FOR THE TREATMENT OF PSYCHOTIC DISORDERS MEMORY PHARMACEUTICALS CORPORATION (US) 2009-05-28 WO disclosed